Breaking News

Tweet TWEET

Horizon Pharma to Present at the 25th Annual ROTH Conference

Horizon Pharma to Present at the 25th Annual ROTH Conference 
DEERFIELD, IL -- (Marketwire) -- 03/11/13 --  Horizon Pharma, Inc.
(NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman,
president and chief executive officer will present at the 25th Annual
ROTH Conference on Monday, March 18th at 8:30a.m. Pacific Time in
Laguna Nigel, CA. Mr. Walbert will provide an overview of the Company
and its corporate activities. 
The presentation will be webcast live and may be accessed by visiting
Horizon's website at http://ir.horizon-pharma.com. A replay of the
webcast will be available for 10 business days. 
About Horizon Pharma
 Horizon Pharma, Inc. is a specialty
pharmaceutical company that has developed and is commercializing
DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic
needs in arthritis, pain and inflammatory diseases. The Company's
strategy is to develop, acquire, in-license and/or co-promote
additional innovative medicines where it can execute a targeted
commercial approach in specific therapeutic areas while taking
advantage of its commercial strengths and the infrastructure the
Company has put in place. For more information, please visit
www.horizonpharma.com. 
Contacts
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
investor-relations@horizonpharma.com 
Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
kgalante@burnsmc.com